Cargando…
Identification of Ganglioside GM3 Molecular Species in Human Serum Associated with Risk Factors of Metabolic Syndrome
Serum GM3 molecular species were quantified in 125 Japanese residents using tandem mass spectrometry multiple reaction monitoring. Individuals were categorized by the presence or absence of metabolic disease risk factors including visceral fat accumulation, hyperglycemia and dyslipidemia. A total of...
Autores principales: | Veillon, Lucas, Go, Shinji, Matsuyama, Wakana, Suzuki, Akemi, Nagasaki, Mika, Yatomi, Yutaka, Inokuchi, Jin-ichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4477979/ https://www.ncbi.nlm.nih.gov/pubmed/26102277 http://dx.doi.org/10.1371/journal.pone.0129645 |
Ejemplares similares
-
Homeostatic and pathogenic roles of GM3 ganglioside molecular species in TLR4 signaling in obesity
por: Kanoh, Hirotaka, et al.
Publicado: (2020) -
Physiopathological function of hematoside (GM3 ganglioside)
por: INOKUCHI, Jin-ichi
Publicado: (2011) -
Ganglioside GM3 Synthase Deficiency in Mouse Models and Human Patients
por: Inamori, Kei-ichiro, et al.
Publicado: (2022) -
Pathophysiological Significance of GM3 Ganglioside Molecular Species With a Particular Attention to the Metabolic Syndrome Focusing on Toll-Like Receptor 4 Binding
por: Inokuchi, Jin-ichi, et al.
Publicado: (2022) -
Serum GM3(d18:1-16:0) and GM3(d18:1-24:1) levels may be associated with lymphoma: An exploratory study with haematological diseases
por: Nishikawa, Masako, et al.
Publicado: (2019)